β-Shell
β-Cath
novel β-Gels
Pancreatic islets
future stem cell sources of β
insulin-sensitive diabetes mellitus
long-term Efficacy Diabetes mellitus
long-term clinical efficacy
insulin resistance
insulin-sensitive T2 diabetics
inadequate insulin production
short supply of donor islets
localised delivery of efficacy cues
current clinical procedure
Pancreatic islet transplantation
immunosuppressive agents
interactive hydrogels
future treatment
protective macrocapsule
O-Fold
omental fold
DRIVE consortium
induced pluripotent stem cell experts
biofunctionalised injectable hydrogels
novel suite of bio
invasive laparoscopic procedure
porous retrievable macrocapsule
extended residence time
effects of lifelong systemic immunosuppressive therapy
tuneable degradation profiles
polymeric microparticles
chronic disease
promising cure
enhanced Viability
high blood glucose
specialised injection catheter
at-risk brittle Type
transport
broader range of T1
poor survival
compatibility
result
targeted deposition
safe handling
engraftment
portal vein
T1D
application
vascularisation
retention
peritoneum
Implants
ISDM
demand drug release systems
vitro models
optimised yield
oxygenation
immunoprotection
improved glycemic control
cells
ease of storage
sufferers
behaviour
preservation technologies
people